Copyright Reports & Markets. All rights reserved.

Global Haloperidol Decanoate API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Haloperidol Decanoate API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Haloperidol Decanoate API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection
    • 1.4.3 Others
  • 1.5 Global Haloperidol Decanoate API Market Size & Forecast
    • 1.5.1 Global Haloperidol Decanoate API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Haloperidol Decanoate API Sales Quantity (2021-2032)
    • 1.5.3 Global Haloperidol Decanoate API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 JANSSEN PHARMACEUTICA NV
    • 2.1.1 JANSSEN PHARMACEUTICA NV Details
    • 2.1.2 JANSSEN PHARMACEUTICA NV Major Business
    • 2.1.3 JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Product and Services
    • 2.1.4 JANSSEN PHARMACEUTICA NV Haloperidol Decanoate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 JANSSEN PHARMACEUTICA NV Recent Developments/Updates
  • 2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD
    • 2.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD Details
    • 2.2.2 TEVA PHARMACEUTICAL INDUSTRIES LTD Major Business
    • 2.2.3 TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Product and Services
    • 2.2.4 TEVA PHARMACEUTICAL INDUSTRIES LTD Haloperidol Decanoate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 TEVA PHARMACEUTICAL INDUSTRIES LTD Recent Developments/Updates
  • 2.3 OLON SPA
    • 2.3.1 OLON SPA Details
    • 2.3.2 OLON SPA Major Business
    • 2.3.3 OLON SPA Haloperidol Decanoate API Product and Services
    • 2.3.4 OLON SPA Haloperidol Decanoate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 OLON SPA Recent Developments/Updates
  • 2.4 MSN LIFE SCIENCES PRIVATE LTD
    • 2.4.1 MSN LIFE SCIENCES PRIVATE LTD Details
    • 2.4.2 MSN LIFE SCIENCES PRIVATE LTD Major Business
    • 2.4.3 MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Product and Services
    • 2.4.4 MSN LIFE SCIENCES PRIVATE LTD Haloperidol Decanoate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MSN LIFE SCIENCES PRIVATE LTD Recent Developments/Updates
  • 2.5 MANKIND PHARMA LTD
    • 2.5.1 MANKIND PHARMA LTD Details
    • 2.5.2 MANKIND PHARMA LTD Major Business
    • 2.5.3 MANKIND PHARMA LTD Haloperidol Decanoate API Product and Services
    • 2.5.4 MANKIND PHARMA LTD Haloperidol Decanoate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MANKIND PHARMA LTD Recent Developments/Updates

3 Competitive Environment: Haloperidol Decanoate API by Manufacturer

  • 3.1 Global Haloperidol Decanoate API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Haloperidol Decanoate API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Haloperidol Decanoate API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Haloperidol Decanoate API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Haloperidol Decanoate API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Haloperidol Decanoate API Manufacturer Market Share in 2025
  • 3.5 Haloperidol Decanoate API Market: Overall Company Footprint Analysis
    • 3.5.1 Haloperidol Decanoate API Market: Region Footprint
    • 3.5.2 Haloperidol Decanoate API Market: Company Product Type Footprint
    • 3.5.3 Haloperidol Decanoate API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Haloperidol Decanoate API Market Size by Region
    • 4.1.1 Global Haloperidol Decanoate API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Haloperidol Decanoate API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Haloperidol Decanoate API Average Price by Region (2021-2032)
  • 4.2 North America Haloperidol Decanoate API Consumption Value (2021-2032)
  • 4.3 Europe Haloperidol Decanoate API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Haloperidol Decanoate API Consumption Value (2021-2032)
  • 4.5 South America Haloperidol Decanoate API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Haloperidol Decanoate API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 5.2 Global Haloperidol Decanoate API Consumption Value by Type (2021-2032)
  • 5.3 Global Haloperidol Decanoate API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 6.2 Global Haloperidol Decanoate API Consumption Value by Application (2021-2032)
  • 6.3 Global Haloperidol Decanoate API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 7.2 North America Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 7.3 North America Haloperidol Decanoate API Market Size by Country
    • 7.3.1 North America Haloperidol Decanoate API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Haloperidol Decanoate API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Haloperidol Decanoate API Market Size by Country
    • 8.3.1 Europe Haloperidol Decanoate API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Haloperidol Decanoate API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Haloperidol Decanoate API Market Size by Region
    • 9.3.1 Asia-Pacific Haloperidol Decanoate API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Haloperidol Decanoate API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 10.2 South America Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 10.3 South America Haloperidol Decanoate API Market Size by Country
    • 10.3.1 South America Haloperidol Decanoate API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Haloperidol Decanoate API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Haloperidol Decanoate API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Haloperidol Decanoate API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Haloperidol Decanoate API Market Size by Country
    • 11.3.1 Middle East & Africa Haloperidol Decanoate API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Haloperidol Decanoate API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Haloperidol Decanoate API Market Drivers
  • 12.2 Haloperidol Decanoate API Market Restraints
  • 12.3 Haloperidol Decanoate API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Haloperidol Decanoate API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Haloperidol Decanoate API
  • 13.3 Haloperidol Decanoate API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Haloperidol Decanoate API Typical Distributors
  • 14.3 Haloperidol Decanoate API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Haloperidol Decanoate API market size was valued at US$ 624 million in 2025 and is forecast to a readjusted size of US$ 824 million by 2032 with a CAGR of 4.1% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Haloperidol Decanoate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Haloperidol Decanoate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Haloperidol Decanoate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Haloperidol Decanoate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Haloperidol Decanoate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Haloperidol Decanoate API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Haloperidol Decanoate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JANSSEN PHARMACEUTICA NV, TEVA PHARMACEUTICAL INDUSTRIES LTD, OLON SPA, MSN LIFE SCIENCES PRIVATE LTD, MANKIND PHARMA LTD, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Haloperidol Decanoate API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Injection
    Others
    Major players covered
    JANSSEN PHARMACEUTICA NV
    TEVA PHARMACEUTICAL INDUSTRIES LTD
    OLON SPA
    MSN LIFE SCIENCES PRIVATE LTD
    MANKIND PHARMA LTD
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Haloperidol Decanoate API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Haloperidol Decanoate API, with price, sales quantity, revenue, and global market share of Haloperidol Decanoate API from 2021 to 2026.
    Chapter 3, the Haloperidol Decanoate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Haloperidol Decanoate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Haloperidol Decanoate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Haloperidol Decanoate API.
    Chapter 14 and 15, to describe Haloperidol Decanoate API sales channel, distributors, customers, research findings and conclusion.

    Buy now